FDA Approved: ALENDRONATE SODIUM — Supplemental Application (Amneal Pharmaceuticals of New York LLC)

View source ↗

Summary

FDA approved a supplemental application for ALENDRONATE SODIUM submitted by Amneal Pharmaceuticals of New York LLC (ANDA075710).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucocorticoid-induced Osteoporosis
• Osteoporosis
• Paget Disease of Bone
• Postmenopausal Osteoporosis

Drugs mentioned

• ALENDRONATE SODIUM (ALENDRONATE SODIUM)

Snippet

SUPPL AP for ALENDRONATE SODIUM (ALENDRONATE SODIUM)